KEVIN BUCHI

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Alaunos Therapeutics, Inc.

Filing Date Source Excerpt
2021-04-07 Kevin Buchi ... Director ... 2020 ... 65 ... The current members of the audit committee are Mr. Kevin Buchi, who serves as the committee’s Chair, Mr. Holger Weis and Ms. Mary Thistle. ... Kevin Buchi ... 272,135

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-14